BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 3028461)

  • 1. HLA antigens in colorectal tumours--low expression of HLA class I antigens in mucinous colorectal carcinomas.
    van den Ingh HF; Ruiter DJ; Griffioen G; van Muijen GN; Ferrone S
    Br J Cancer; 1987 Feb; 55(2):125-30. PubMed ID: 3028461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-co-ordinate expression of HLA-DR antigens and invariant chain.
    Momburg F; Möller P
    Immunology; 1988 Mar; 63(3):551-3. PubMed ID: 3280476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of HLA-DR, HLA-DP, HLA-DQ and associated invariant chain (Ii) in normal colorectal mucosa, adenoma and carcinoma.
    Degener T; Momburg F; Möller P
    Virchows Arch A Pathol Anat Histopathol; 1988; 412(4):315-22. PubMed ID: 3125670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of polymorphic A and B locus HLA antigens in colon carcinoma.
    Rees RC; Buckle AM; Gelsthorpe K; James V; Potter CW; Rogers K; Jacob G
    Br J Cancer; 1988 Apr; 57(4):374-7. PubMed ID: 3291922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Class I and II HLA antigen distribution in normal mucosa, adenoma and colon carcinoma: relation with malignancy and invasiveness.
    Gutierrez J; López-Nevot MA; Cabrera T; Oliva R; Esquivias J; Ruiz-Cabello F; Garrido F
    Exp Clin Immunogenet; 1987; 4(3):144-52. PubMed ID: 2856203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction or loss of HLA-A,B,C antigens in colorectal carcinoma appears not to influence survival.
    Stein B; Momburg F; Schwarz V; Schlag P; Moldenhauer G; Möller P
    Br J Cancer; 1988 Apr; 57(4):364-8. PubMed ID: 2839218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of HLA-D sub-region products on human colorectal carcinoma.
    Ghosh AK; Moore M; Street AJ; Howat JM; Schofield PF
    Int J Cancer; 1986 Oct; 38(4):459-64. PubMed ID: 2428757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of colorectal tumor epithelium expressing HLA-D/DR with CD8-positive T-cells and mononuclear phagocytes.
    Allen CA; Hogg N
    Cancer Res; 1987 Jun; 47(11):2919-23. PubMed ID: 3105871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The membrane antigens of human colorectal cancer cells: demonstration with monoclonal antibodies of heterogeneity within and between tumours and of anomalous expression of HLA-DR.
    Daar AS; Fabre JW
    Eur J Cancer Clin Oncol; 1983 Feb; 19(2):209-20. PubMed ID: 6337854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical analysis of HLA antigens and mononuclear infiltrates of benign and malignant breast.
    Zuk JA; Walker RA
    J Pathol; 1987 Aug; 152(4):275-85. PubMed ID: 3312546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of histocompatibility antigens and characterization of mononuclear cell infiltrates in normal and neoplastic colorectal tissues of humans.
    Umpleby HC; Heinemann D; Symes MO; Williamson RC
    J Natl Cancer Inst; 1985 Jun; 74(6):1161-8. PubMed ID: 3158771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in the expression of mucus-associated antigens between proximal and distal human colon adenocarcinomas.
    Bara J; Nardelli J; Gadenne C; Prade M; Burtin P
    Br J Cancer; 1984 Apr; 49(4):495-501. PubMed ID: 6324842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of HLA-A,B,C in colorectal carcinoma is related to the degree of de-differentiation.
    Momburg F; Möller P; Moldenhauer G; Hämmerling GJ
    J Immunogenet; 1986; 13(2-3):195-9. PubMed ID: 3469275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histocompatibility antigens in primary and metastatic squamous cell carcinoma of the larynx.
    Esteban F; Concha A; Huelin C; Pérez-Ayala M; Pedrinaci S; Ruiz-Cabello F; Garrido F
    Int J Cancer; 1989 Mar; 43(3):436-42. PubMed ID: 2647639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of HLA-A,B,C and de novo expression of HLA-D in colorectal cancer.
    Momburg F; Degener T; Bacchus E; Moldenhauer G; Hämmerling GJ; Möller P
    Int J Cancer; 1986 Feb; 37(2):179-84. PubMed ID: 2417962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The presence of oncofoetal antigens in large bowel carcinoma.
    Ma J; De Boer WG; Nayman J
    Aust N Z J Surg; 1982 Feb; 52(1):30-4. PubMed ID: 6280663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inappropriate mucin production in endodermal carcinoma--one point of view.
    Nayman J; De Boer WG; Ma J
    Jpn J Surg; 1983 Jul; 13(4):317-23. PubMed ID: 6316004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucinous colorectal carcinoma: immunopathology and prognosis.
    Pihl E; Nairn RC; Hughes ES; Cuthbertson AM; Rollo AJ
    Pathology; 1980 Jul; 12(3):439-47. PubMed ID: 6253864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MHC class I and II antigens on gastric carcinomas and autologous mucosa.
    Ferron A; Perez-Ayala M; Concha A; Cabrera T; Redondo M; Oliva MR; Ruiz-Cabello F; Garrido F
    J Immunogenet; 1989; 16(4-5):413-23. PubMed ID: 2639912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical localization of the epithelial marker MAM-6 in invasive malignancies and highly dysplastic adenomas of the large intestine.
    Zotter S; Lossnitzer A; Hageman PC; Delemarre JF; Hilkens J; Hilgers J
    Lab Invest; 1987 Aug; 57(2):193-9. PubMed ID: 3613527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.